Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

October 09, 2001; 57 (7) Clinical/Scientific Notes

Association of a tumor necrosis factor α polymorphism with MS susceptibility

Brian G. Weinshenker, David D. Hebrink, Elizabeth Atkinson, Orhun H. Kantarci
First published October 9, 2001, DOI: https://doi.org/10.1212/WNL.57.7.1341
Brian G. Weinshenker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David D. Hebrink
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Atkinson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Orhun H. Kantarci
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Association of a tumor necrosis factor α polymorphism with MS susceptibility
Brian G. Weinshenker, David D. Hebrink, Elizabeth Atkinson, Orhun H. Kantarci
Neurology Oct 2001, 57 (7) 1341-1342; DOI: 10.1212/WNL.57.7.1341

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
334

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Fernandez–Arquero et al.1 reported that a promoter region polymorphism in the tumor necrosis factor α gene, TNFA-376A, was associated with susceptibility to MS in Spain. We previously performed a comprehensive screen of the promoter region, all exons, and their splice junction regions of TNFA2 and reported no association of the TNFA-308 polymorphism with MS.3 Our screen began at position −353 in the promoter region; therefore, we did not identify the TNFA-376A variant, which is just 5′ to the sequence that we screened. We evaluated the findings of Fernandez–Arquero et al.1 in our population.

Methods.

We studied the putative association of this variant in case-control analysis. Cases consisted of 121 patients, who constituted 73% of a prevalence cohort of patients with MS in Olmsted County, MN. Controls consisted of 243 patients who were rigorously matched for age, sex, and ethnicity, as described elsewhere.4 We used allele-specific PCR to genotype patients for this polymorphism. Two allele-specific reactions were developed using “mutant” and “wild-type” allele-specific primers. The specific primer for the mutant allele was downstream 5′GGC ATC CTG TCT GGA AA, and the specific primer for wild-type allele was downstream 5′ CCC ATC CTG TCT GGA AG. The nonspecific upstream primer was 5′ CGG ATC ATG CTT TCA GTG; allele-specific nucleotides are italicized. The reactions were optimized to obtain the appropriate product size and were subsequently optimized to achieve specificity using controls whose genotype was determined by sequencing. The annealing temperature was 54 °C for the reaction to determine the mutant allele and 58 °C to determine the wild-type allele. A second downstream primer was incorporated into the reactions to yield a nonspecific band to prove the integrity of the reaction when the specific allele that is being tested is absent.

Results.

Our results and those reported by Fernandez–Arquero et al.1 are summarized and contrasted in the table. Our results do not show a significant association with MS. In fact, different from the Spanish study, carriers of the A allele were more frequent in the controls than in cases.

View this table:
  • View inline
  • View popup
Table 1.

Frequency of the TNFA-376 polymorphism

Discussion.

Fernandez–Arquero et al.1 reported linkage dysequilibrium of the TNFA-376A allele with DRB1*0301, DQA1*0501, DQB1*0201 haplotype, but found that the TNFA-376A allele was associated with MS in patients positive and negative for this major histocompatibility complex haplotype. There was an apparent synergistic effect with DRB1*1501, which is associated with predisposition to MS worldwide. Too few individuals in our population carried this allele to permit an evaluation of linkage dysequilibrium or synergistic effects.

The lower allele frequency of the TNFA-376A allele in our population, in patients with MS and in controls, reduced the power to detect an association. In this North American sample composed primarily of people of German, Scandinavian, and British descent, there is no apparent excess of TNFA-376A allele polymorphism in patients with MS compared with controls rigorously matched for ethnicity. Assuming that our inability to replicate the results is not merely an issue of power, the association described by Fernandez–Arquero et al.1 is a population-specific association or a chance (false-positive) result.

Acknowledgments

Supported by the National Multiple Sclerosis Society.

Footnotes

  • See also pages 1153 and 1304

  • Received April 6, 2001.
  • Accepted May 17, 2001.

References

  1. ↵
    Fernandez–Arquero M, Arroyo R, Rubio A, et al. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology . 1999; 53: 1361–1363.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Weinshenker BG, Wingerchuk DM, Liu Q, Bissonet AS, Schaid DJ, Sommer SS. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology . 1997; 49: 378–385.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Wingerchuk D, Liu Q, Sobell J, Sommer S, Weinshenker BG. A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis. Neurology . 1997; 49: 626–628.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG. Association of two variants in IL-1 beta and IL-1 receptor antagonist genes with multiple sclerosis. J Neuroimmunol . 2000; 106: 220–227.
    OpenUrlCrossRefPubMed
View Abstract

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Methods.
    • Results.
    • Discussion.
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • Genetic association studiesGenes in search of diseases
  • Dopaminergic neurotransmission and restless legs syndrome: A genetic association analysis

Topics Discussed

  • Multiple sclerosis
  • Association studies in genetics

Alert Me

  • Alert me when eletters are published
Neurology: 99 (6)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise